Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 438 results found. Search for [ Serum Institute of India vaccine trials ]

Results 1 to 21 of 438
Associated Press
June 19, 2021
Paul defended the government's move to restrict vaccine exports in April as it battled a ferocious surge in infections


BusinessToday.In
June 17, 2021
Novavax's COVID-19 vaccine has shown 90.4 per cent efficacy in Phase 3 trials, putting it in the same league as other vaccines including Pfizer-BioNTech (91.3 per cent) and Moderna (90 per cent)


Joe C Mathew
June 15, 2021
Bharat Biotech says less than 10 percent of its total production of Covaxin has so far been supplied to private hospitals, while most of the remaining quantity was supplied to state and central governments


BusinessToday.In
June 9, 2021
The Hyderabad-based company said it will apply for full licence for Covaxin after the release of phase-III data.


BusinessToday.In
June 8, 2021
Around 30 per cent of the advance for procurement of both vaccines has been released to Serum Institute of India and Bharat Biotech, the health ministry said


BusinessToday.In
New Delhi, June 5, 2021
The Delhi High Court on Friday dismissed the lawsuit by actress Juhi Chawla against the implementation of 5G network technology in the country and imposed a fine of Rs 20 lakh on the plaintiffs; The Drugs Controller General of India (DGCI) on Friday granted permission to the Serum Institute of India (SII) to manufacture the Russian Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, according to official sources; A recent study conducted by scientists of INSACOG and the National Centre for Disease Control (NCDC) has shown that despite having a high seropositivity rate of 56 per cent, people of Delhi got little protection against the Delta variant of the coronavirus. Watch this and more on News Blast.Also Read: Jabalpur-based firm to produce Amphotericin-B to treat black fungus


Shailendra Shukla
New Delhi, June 5, 2021
'Publicity': Delhi HC junks Juhi Chawla's suit against 5G; imposes Rs 20-lakh fineThe Delhi High Court on Friday dismissed the lawsuit by actress Juhi Chawla against the implementation of 5G network technology in the country. The court ruled the plea was filed to gain \"publicity\" and that the plaintiffs, Chawla and two others, have abused the process of law. The Delhi High Court has imposed a fine of Rs 20 lakh on the plaintiffs. After the court pronounced the judgement, Chawla's counsel s...


Reuters
June 3, 2021
So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the world's second-most populous country reels from a devastating second wave of infections


BusinessToday.In
New Delhi, June 3, 2021
Pune-based Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday. Russia's RDIF sovereign wealth fund, which is marketing Sputnik V globally, has already signed agreements with six leading Indian manufacturers including Dr Reddy's Laboratories, Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma and Virchow Biotech. The vaccine is currently being manufactured in India by Dr Reddy's Laboratories. The SII has also sought approval for test analysis and examination. Once permitted, the company will need to conduct clinical trials. Watch the video for more.Also Read: Serum Institute seeks nod for licence to manufacture Sputnik V in India


BusinessToday.In
June 3, 2021
Foreign pharma majors, such as Pfizer and Moderna, have said that they will export their COVID-19 vaccines to India only if the deal is the Indian government and the company is guarded against legal cases for any severe side effects


BusinessToday.In
June 3, 2021
Once the company gets permission, it will have to conduct clinical trials and if successful, the Serum Institute will become the seventh company to manufacture Sputnik V


BusinessToday.In
June 3, 2021
This development comes a day after reports suggested that the Centre is leaning towards granting indemnity to foreign vaccine makers including Pfizer and Moderna


PB Jayakumar
June 2, 2021
The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum.


Reuters
June 1, 2021
Biological E. will run a clinical trial of Providence's vaccine in India and seek emergency use approval for it, the company said in a statement


Rashi Bisaria
New Delhi, May 31, 2021
COVID-19: Serum Institute to supply 10 crore doses of Covishield in JuneSerum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 10 crore doses of Covishield in June, official sources said on Sunday amid complaint by states about the shortage of anti-coronavirus vaccine jabs. In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandem...


PTI
May 30, 2021
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.


PB Jayakumar
May 28, 2021
COVAX has delivered over 70 million doses to 126 countries around the world since February, in the largest and most complex rollout of vaccines in history


Reuters
May 27, 2021
India has been inoculating its people with the AstraZeneca vaccine produced locally at the Serum Institute, Covaxin made by local firm Bharat Biotech, and has begun rolling out Russia's Sputnik V


Dr Srivatsa Krishna
New Delhi, May 26, 2021
While there are many critics of the government's vaccine strategy, over 75% of 18+ Indians could be vaccinated by October '21


BusinessToday.In
May 24, 2021
The company is aiming to submit the emergency use application by June. \"We still think we should be able to submit (the vaccine for emergency use authorisation) in May,\" MD Sharvil Patel said


PAGES 1 OF 22  12345